Investor call intimation
Awaiting price reaction for this filing.
Eris Lifesciences has informed the stock exchanges that it will hold a conference call/webcast for analysts and investors on Monday, May 19, 2025, at 4:00 PM IST. The call is to discuss the company's financial and operational performance for Q4 and FY25. This follows the Board's meeting scheduled to approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2025. The webcast link has been shared and is also available on the company's website. The filing was made under SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations.
This is a routine regulatory disclosure announcing the investor call. The actual financial results and any management commentary on May 19 will be the key driver for stock movement; this filing itself is unlikely to cause immediate price action.